GSD-1 (glycogen storage disease type 1) is caused by an inherited defect in glucose-6-phosphatase activity, resulting in a massive accumulation of hepatic glycogen content and an induction of de novo lipogenesis. The chlorogenic acid derivative S4048 is a pharmacological inhibitor of the glucose 6-phosphate transporter, which is part of glucose-6-phosphatase, and allows for mechanistic studies concerning metabolic defects in GSD-1. Treatment of mice with S4048 resulted in an ~60% reduction in blood glucose, increased hepatic glycogen and triacylglycerol (triglyceride) content, and a markedly enhanced hepatic lipogenic gene expression. In mammals, hepatic expression of lipogenic genes is regulated by the co-ordinated action of the transcription factors SREBP (sterol-regulatory-element-binding protein)-1c, LXRα (liver X receptor α) and ChREBP (carbohydrate-response-element-binding protein). Treatment of Lxra−/− mice and Chrebp−/− mice with S4048 demonstrated that ChREBP, but not LXRα, mediates the induction of hepatic lipogenic gene expression in this murine model of GSD-1. Thus ChREBP is an attractive target to alleviate derangements in lipid metabolism observed in patients with GSD-1.
Skip Nav Destination
Close
Article navigation
December 2010
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
November 12 2010
Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1
Aldo Grefhorst
;
*Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
2To whom correspondence should be addressed (email a.grefhorst@med.umcg.nl).
Search for other works by this author on:
Marijke Schreurs
;
Marijke Schreurs
1
†Molecular Genetics Section, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other works by this author on:
Maaike H. Oosterveer
;
Maaike H. Oosterveer
*Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other works by this author on:
Victor A. Cortés
;
Victor A. Cortés
‡Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, U.S.A.
Search for other works by this author on:
Rick Havinga
;
Rick Havinga
*Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other works by this author on:
Andreas W. Herling
;
Andreas W. Herling
§Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany
Search for other works by this author on:
Dirk-Jan Reijngoud
;
Dirk-Jan Reijngoud
∥Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Search for other works by this author on:
Albert K. Groen
;
Albert K. Groen
*Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
∥Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Search for other works by this author on:
Folkert Kuipers
Folkert Kuipers
*Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
∥Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Search for other works by this author on:
Biochem J (2010) 432 (2): 249–254.
Article history
Received:
August 12 2010
Revision Received:
September 13 2010
Accepted:
September 20 2010
Accepted Manuscript online:
September 20 2010
Citation
Aldo Grefhorst, Marijke Schreurs, Maaike H. Oosterveer, Victor A. Cortés, Rick Havinga, Andreas W. Herling, Dirk-Jan Reijngoud, Albert K. Groen, Folkert Kuipers; Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1. Biochem J 1 December 2010; 432 (2): 249–254. doi: https://doi.org/10.1042/BJ20101225
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Related Articles
Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes
Biochem J (September,2001)
Use of α-toxin from Staphylococcus aureus to test for channelling of intermediates of glycolysis between glucokinase and aldolase in hepatocytes
Biochem J (December,2000)